Exome Asset Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.27M | Buy |
153,278
+35,261
| +30% | +$522K | 1.69% | 21 |
|
|
2025
Q1 | $2.11M | Buy |
+118,017
| New | +$2.11M | 1.88% | 24 |
|
|
2024
Q3 | – | Sell |
-443,379
| Closed | -$3.64M | – | 79 |
|
|
2024
Q2 | $3.64M | Buy |
443,379
+80,892
| +22% | +$665K | 3.24% | 9 |
|
|
2024
Q1 | $2.79M | Buy |
362,487
+278,500
| +332% | +$2.15M | 2.39% | 15 |
|
|
2023
Q4 | $755K | Buy |
+83,987
| New | +$755K | 0.75% | 41 |
|